Items Tagged ‘clinical trials’
November 17, 2020
Early-stage clinical trial provides hope for patients with traumatic spinal cord injuries
By Advancing the Science contributor 
Early research at Mayo Clinic is a step toward hope for a future treatment for patients with traumatic spinal cord injury. The research in this article discusses the experience related to the first case in a phase I safety study of mesenchymal stem cell treatment for spinal cord injury. The case study, found in Mayo Clinic […]
Tags: Allan Dietz, clinical trials, Mayo Clinic Proceedings, Mohamad Bydon, neurology, neurosurgery, regenerative medicine, spinal cord injury, Wenchun Qu
November 6, 2020
Long-term safety, benefits of stem cell therapy for heart failure
The largest regenerative medicine clinical trial to date for heart failure finds stem cell therapy is safe over the long term and benefits patients with advanced left ventricular enlargement. This multinational research, co-led by Andre Terzic, M.D., Ph.D., director of Mayo Clinic’s Center for Regenerative Medicine, and published in ESC Heart Failure, offers guidance in […]
Tags: Andre Terzic, cardiovascular disease, Center for Regenerative Medicine, clinical research, clinical trials, heart failure, stem cell research, stem cell therapy
October 26, 2020
Mayo Clinic Research in the news — 10/26/2020
At Mayo Clinic, patient care is evidence-based, meaning research drives the practice of medicine. Our scientists and clinician researchers are at work across the spectrum of health and the delivery of health care, seeking better outcomes and enhanced experiences while managing the total costs of care. Curable dementia, pot and opioids, childcare during COVID-19, and […]
Tags: Alzheimer's disease, Andrew Badley, artificial intelligence, autoimmune disorder, biomarkers, cardiovascular medicine, Charles Adler, clinical research, clinical trials, COVID-19, David Knopman, dementia
October 19, 2020
Mayo Clinic Research in the news — 10/19/2020
The news media recently highlighted a range of interesting topics, featuring Mayo Clinic Research and researchers on a new way to hunt down and capture deadly brain cancer cells, MSG in food, Angelman syndrome, the connection between screen time and life expectancy, COVID-19 (of course), and much more. Read on for brief excerpts and links […]
Tags: acute myeloid leukemia, aging, Angelman syndrome, artificial intelligence, biomarkers, brain cancer, cancer, cancer research, Center for Digital Health, clinical trials, collaboration, COVID-19
October 9, 2020
Mayo Clinic Research in the news — 10/9/2020
While Mayo Clinic has long been known as a clinical powerhouse, only more recently has the world actively noted our Research and Education shields. This increased awareness has led to visibility for both our research and our researchers in national and international news and education forums. In the past week, they have been featured in […]
Tags: Alzheimer's disease, amnesia, antibodies, Barry Borlaug, biomarkers, biostatistics, blood pressure, Bobbi Pritt, clinical trials, Colin West, community engagement, Cornelius Thiels
September 30, 2020
By Susan Murphy
Patients with a rare genetic disease called familial adenomatous polyposis, (FAP), often face debilitating challenges. Typically striking in the early teenage years, FAP is characterized by hundreds to thousands of tiny polyps forming in the colon and rectum and leading to a nearly 100% percent likelihood that they will get colon cancer without a life-altering surgery […]
Tags: cancer screening, Center for Individualized Medicine, clinical trials, colon cancer, colon polyp, colorectal cancer, gene mutation, genetic testing, hereditary diseases, Niloy "Jewel" Samadder, rare disease
September 29, 2020
Study moves microbiome-based therapies closer to the mainstream treatment for C. difficile infection
By Advancing the Science contributor
A new study published online in the journal Clinical Infectious Diseases looked at the use of a non-frozen capsule of microbiome restoration therapy for treating patients with recurrent C. difficile infection. “Patients with C. difficile are typically managed with antibiotics or fecal transplantation for recurrent C. difficile,” says the study’s author, Sahil Khanna, M.B.B.S., a gastroenterologist at Mayo […]
Tags: C. diff, clinical trials, fecal transplant, gastroenterology, microbiome, Sahil Khanna
September 25, 2020
Mayo Clinic Research in the news — 9/25/2020
COVID-19 still is holding a spot in the headlines, and probably will for at least the next year or so. But more and more there is re-emerging interest in other health care research. In this post, you’ll find Mayo Clinic Research and research experts cited on Alzheimer’s, opioids, artificial intelligence and physician burnout, seafood and […]
Tags: Andrew Badley, artificial intelligence, big data, bile duct cancer, Bobbie Gostout, brain, cancer, cardiology, cardiovascular disease, cholangiocarcinoma, clinical research, clinical trials
September 11, 2020
Mayo Clinic Research in the news — 9/11/2020
In case you missed them – or you just weren’t looking, this blog post includes a host of stories, from across the nation and around the world, that discuss Mayo Clinic research or cite Mayo researchers. Read on for excerpts and links to stories on what we know about herbs and supplements for anxiety, proposed […]
Tags: Alzheimer's disease, arthritis, autoimmune disorder, Bhanu Kolla, Brent Bauer, cancer screening, celiac disease, clinical research, clinical trials, concussion, COVID-19, dementia
September 3, 2020
By Advancing the Science contributor
Heart patients who undergo percutaneous coronary intervention (PCI) or stent placement― nonsurgical procedures to improve blood flow to the heart ― are typically prescribed anti-platelet therapy to avoid blood clots that can lead to a heart attack or stroke. New research from the international TAILOR-PCI trial, the largest pharmacogenetics clinical trial in cardiology, suggests that genetic testing could […]
Tags: antiplatelet, cardiology, Center for Individualized Medicine, Charanjit Rihal, clinical trials, coronary artery disease, gene varient, genetics, heart disease, Kent Bailey, Michael Farkouh, Naveen Pereira